To investigate whether the decrease in PABPN1 expression can explain the tissue specificity in OPMD, PABPN1 levels in blood samples of OPMD patients and controls was determined using RT-qPCR. The gene discussed is PABPN1; the disease is oculopharyngeal muscular dystrophy.